Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ALRN

Aileron Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ALRN:Aileron Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$1.23

EXCHANGE

NASDAQ

SECTOR

Health Care

ALRN
Aileron Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ALRN
Aileron Therapeutics Inc Stock Information
Latest Close Price$1.23
52-Week Low/High$0.52 - $9.88
Percent Held by Institutions0.00%
Revenue$0
Net Income$-38,812,000
Cash Flow$-6,878,000
EPS-0.50%
Market Cap$18,140,040
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-87.21%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateJan. 18, 2019
ALRN
Aileron Therapeutics Inc Dividend Payment History

No Data available for Payment History.

ALRN
Aileron Therapeutics Inc Other Details

Aileron Therapeutics is clinical-stage biopharmaceutical company. Co. is focused on developing and commercializing a class of therapeutics called stapled peptides. Co.'s product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of variety of cancers. ALRN-6924, which is being tested in multiple clinical trials, reactivates p53-mediated tumor suppression by targeting the two primary p53 suppressor proteins, MDMX and MDM2.

Web Sitewww.aileronrx.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Aileron Therapeutics Inc Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE DECREASE: Aileron Therapeutics Inc (NASDAQ: ALRN) on 01-19-2019 decreased close price > 10% from $1.48 to $1.23

Read more...

Jan. 17, 2019CLOSE PRICE INCREASE: Aileron Therapeutics Inc (NASDAQ: ALRN) on 01-17-2019 increased close price > 10% from $1.14 to $1.47

Read more...

Jan. 15, 2019CLOSE PRICE INCREASE: Aileron Therapeutics Inc (NASDAQ: ALRN) on 01-15-2019 increased close price > 10% from $0.96 to $1.07

Read more...
More Aileron Therapeutics Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-19-2019 increased close price > 10% from $0.13 to $0.16

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Aradigm Corp. (OTCBB: ARDM) on 01-19-2019 increased close price > 10% from $0.55 to $0.61

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Burzynski Research Institute Inc (OTCBB: BZYR) on 01-19-2019 increased close price > 10% from $0.03 to $0.04

Read more...
More Pharmaceuticals Dividend News
X

Search Dividend Investor